Higher PFAS levels reduce blood sugar improvements after teen bariatric surgery
A new USC study shows teens with higher blood levels of per- and polyfluoroalkyl substances (PFAS) measured before…
New C-COMPASS software opens spatial proteomics and lipidomics to non-coders
A new tool developed by Helmholtz Munich and the German Center for Diabetes Research and the University of…
New technique overcomes technological barrier in 3D brain imaging
Scientists at the Swiss Light Source SLS have succeeded in mapping a piece of brain tissue in 3D…
NewLimit ‘close’ to clinic-ready epigenetic reprogramming therapy
Liver rejuvenation program produces a ‘lead payload’ as biotech begins its journey towards human clinical trials. After several…
Obesity-related metabolic stress may affect brain health far earlier than expected
For decades, scientists have known that what harms the body often harms the brain. Conditions such as obesity,…
New signaling molecule drives development of tissue resident memory T cells
We owe a lot to tissue resident memory T cells (TRM). These specialized immune cells are among the…
Blood group A linked to a higher risk of primary biliary cholangitis
A major retrospective study shows that people with blood group A face a higher likelihood of autoimmune liver…
Study explores how elevated growth hormone levels contribute to liver aging
A new research paper was published in Volume 17, Issue 10 of Aging-US on October 3, 2025, titled “Growth hormone excess…
Understanding leptin’s dual function in MAFLD pathogenesis
Metabolic dysfunction-associated fatty liver disease (MAFLD) has emerged as a predominant chronic liver condition globally, intricately linked with…
Switching APOE4 to APOE2 in adult mice reduces Alzheimer’s pathology and improves memory
By flipping a single genetic switch from APOE4 to APOE2 in adult mice, researchers reversed key Alzheimer’s-like changes…
Study clarifies how biliary atresia overlaps with multiple congenital syndromes
Biliary atresia (BA) represents one of the leading causes of pediatric liver failure, often requiring surgical intervention or…
One-time CRISPR therapy safely lowers cholesterol and triglycerides in early trial
In a 15-patient, Phase 1 one, first-in-human trial, a one-time, CRISPR-Cas9 gene-editing therapy safely reduced LDL cholesterol and…